维普期刊资源整合服务平台（V6.5）

75篇 您的检索式：作者名="Vervenne"

选中清除导出查看参考文献查看引证文献引用追踪共4页首页上一页第1页下一页末页 /4 跳转

	题名	作者	年代	出处	被引量
1	Systemic treatment of oesophageal cancer显示文摘	RICHEL D J VERVENNE W L	2004	Eur Gastrocnterol Hepatol2004，16，3：	1
2	Reduced cortisolmetabolism during critical illness显示文摘	Boonen E Vervenne H Meersseman P	2013	N Engl J Med2013，368，16：	1
3	Systemic treatment of oesophageal cancer 显示文摘	Richel D J Vervenne WL	2004	Eur J Gastroenterol Hepatol2004，16，3：	1
4	Reduced nocturnalACTH-driven cortisol secretion during critical illness显示文摘	Boonen E Meersseman P Vervenne H	2014	Am JPhysiol Endocrinol Metab2014，306，8：	1
5	Systemic treatment of esophageal cancer显示文摘	Richel DJ Vervenne WL	2004	Eur Gastroenterol Hepatol2004，16，3：	1
6	Systemic treatment of oesophageal cancer显示文摘	RICHEL D J VERVENNE W L	2004	Eur J Gastroenterol Hepatol2004，16，3：	1
7	Systemic treatment of oesophageal cancer 显示文摘	Richel D J Vervenne WL	2004	Eur J Gastroenterol Hepatol2004，16，3：	1
8	Phase Ⅲ trial of bevacizumab in combination with gemeitabine and erlotinib in patients with metastatic pancreatic cancer显示文摘	VAN CUTSEM E VERVENNE WJ BENNOUNA J	2009	J Clin Oncol2009，27，13：	1
9	Rash as a marker for the efficacy of gemcitabine plus erlotinib- based therapy in pancreatic cancer: Results from the AViTA study 显示文摘	VAN CUTSEM E VERVENNE WL BENNOUNA J	2009	J Clin Oncol2009，27，15：	1
10	Reduced cortisol metabolism during critical illness显示文摘	Boonen E Vervenne H Meersseman P	2013	N Engl J Med2013，368，16：	1
11	Reduced cortisol metabolism during critical illness 显示文摘	Boonen E Vervenne H Meersseman P	2013	N Engl J Med2013，368，16：	1
12	Phase m trial of bevacizumab in combination with gemcitabine and erlotinib in patients with metastatic pancreatic can- cer显示文摘	van Cutsem E Vervenne WL Bennouna J	2009	J Clin Oncol2009，27，13：	1
13	Protection of macaques against Mycobacterium tuberculosis infection by a subunit vaccine based on a fusion protein of antigen 85B and ESAT-6显示文摘	LANGERMANS J A DOHERTY T M VERVENNE R A	2005	Vaccine2005，23，21：	1
14	Gradient-enhanced response surface building显示文摘	Keulen F V Vervenne K	2004	Structural and Multidisciplinary Optimization2004，27，：	1
15	Phase III trial of bevacizumab in combination with gemcitabi- ne and erlotinib in patients with metastatic pancreatic cancer显示文摘	Van Cutsem E Vervenne WL Bennouna J	2009	J Clin Oncol2009，27，13：	1
16	Phase IiI trial of bevacizumab in combination with gemcitabine and erlotinib in patients with metastatic pancreatic cancer显示文摘	Van Cutsem E Vervenne WL Bennouna J	2009	J Clin Onco12009，27，13：	1
17	Phase III trial of bevacizumab in combination with gemcitabine and erlotinib in patients with metastatic pancreatic cancer显示文摘	Van Cutsem E Vervenne WL Bennouna J	2009	J C/in Oncol2009，27，13：	1
18	Phase III trial of bevacizumab in combination with gemcitabine and erlo- tinib in patients with metastatic pancreatic cancer 显示文摘	Van Cutsem E Vervenne WL Bennouna J	2009	J Clin Oncol2009，27，：	1
19	Phase II1 trial of bevacizumab in combination with gemcitabine and erlo- tinib in patients with metastatic pancreatic cancer 显示文摘	Van Cutsem E Vervenne WL Bennouna J	2009	J Clin Oncol2009，27，13：	1
20	Reduced cortisol metaholism durinl critical illness显示文摘	Boonen E Vervenne H Meersseman P	2013	N EnglJ Med2013，368，16：	1

返回顶部每页显示：

共4页首页上一页第1页下一页末页 /4 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示